中昌國際控股(00859.HK):於到期時悉數贖回可換股票據
格隆匯 12 月 8日丨中昌國際控股(00859.HK)公佈,有關發行可換股票據以支付部份第一收購事項代價。可換股票據已於2020年12月7日到期,而可換股票據的未償還本金額1100萬港元概無轉換為換股股份。公司已於到期時按相當於未償還本金額的100%連同直至到期日的所有累計及未付利息的金額的贖回價1192.4萬港元悉數贖回未償還可換股票據。
公司就悉數贖回事項已付的價格總額乃以公司內部資源撥付。公司認為悉數贖回事項不會對其財務狀況造成重大影響。
悉數贖回事項完成後,可換股票據已全數註銷,而公司根據及就可換股票據所承擔的所有責任已告解除。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.